# Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors

> **NCT06646627** · PHASE1 · RECRUITING · sponsor: **Stanford University** · enrollment: 48 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** B7-H3CART

## Key facts

- **NCT ID:** NCT06646627
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-11
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06646627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06646627, "Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06646627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*